Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulatory Post Marketing Surveillance of Prezista 400mg Tablet

NCT01741831 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT01741831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01741831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulatory Post Marketing Surveillance of Prezista 400mg Tablet
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
October 31, 2016
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immune deficiency syndrome